We show that, despite differences in primary structure, substrate preference, and mechanism of catalysis, yeast DNA topoisomerase I can functionally substitute for Escherichia coli DNA topoisomerase I. A family of plasmids expressing the yeast TOP) gene or 5'-deletion mutations of it were used to complement the temperature-sensitive phenotype of an E. coli topA mutant. These plasmids were then isolated from the cells by a rapid lysis procedure and examined for their degrees of supercoiling. Functional complementation of a conditional-lethal mutation in topA, which encodes E. coli DNA topoisomerase I, correlates with the expression of a catalytically active yeast enzyme that reduces the degree of negative supercoiling of intracellular DNA. We also show that -130 amino acids of the amino-terminal portion of the yeast enzyme can be deleted without affecting its activity in vitro; activity of the enzyme inside E. coli, however, is more sensitive to such deletions.
In eubacteria, as well as in eukaryotes, two classes of DNA topoisomerases have been well-characterized (for reviews, see refs. [1] [2] [3] [4] . The type I topoisomerases break and rejoin one DNA strand at a time in the interconversion of the topological isomers (topoisomers) of DNA rings or loops. In eubacteria, the major type I activity is DNA topoisomerase I; a second type I topoisomerase, DNA topoisomerase III, has been found in Escherichia coli (5, 6) , but a detailed characterization of this enzyme is lacking. In eukaryotes, only one type I enzyme, DNA topoisomerase I, is known.
Bacterial and eukaryotic DNA topoisomerase I differ in several respects and appear to be unrelated structurally. The eukaryotic enzyme interacts preferentially with doublestranded DNA (7) and relaxes positively and negatively supercoiled DNAs to completion (8, 9) . When the enzyme transiently cleaves DNA, it forms a covalent intermediate in which the enzyme is linked to a 3'-phosphoryl end of the cleaved DNA strand (10) . The prokaryotic enzyme, on the other hand, normally relaxes negatively supercoiled DNA (11) ; positively supercoiled DNA is relaxed only if a singlestranded loop is present (12) . The bacterial enzyme becomes covalently linked to a 5'-phosphoryl group when it transiently cleaves DNA (13) . The differences in substrate preference and catalysis between the eukaryotic and prokaryotic enzymes are consistent with the apparent lack of similarity between the amino acid sequences of E. coli topoisomerase I and the yeast Saccharomyces cerevisiae topoisomerase I (14, 15) .
The type II topoisomerases are exemplified by bacterial gyrase and eukaryotic topoisomerase II. They are classified as type II enzymes by virtue of their concerted breakage and rejoining of both strands of a duplex DNA (16, 17) . Whereas both enzymes require ATP, only bacterial gyrase (an A2B2 tetramer) can utilize the chemical energy of ATP hydrolysis for the negative supercoiling of DNA-i.e., the reduction of the linking number of a double-stranded DNA ring to values below that of the same DNA in its most stable configuration. The eukaryotic enzyme (a homodimer) can relax positively or negatively supercoiled DNA but cannot supercoil a relaxed DNA. In contrast to the case of the eubacterial and eukaryotic type I enzymes, gene sequences reveal evolutionary and structural similarities between the type II enzymes (reviewed in ref. 4) .
Functionally, bacterial DNA gyrase is essential (reviewed in refs. [16] [17] [18] . In E. coli, DNA topoisomerase I also affects cell viability. E. coli topA deletion mutants are viable only in the presence of a second compensatory mutation, which often reduces the supercoiling activity of gyrase (19) (20) (21) Fig. 1 ).
To construct 5' deletions in the TOP) gene, plasmid pTP1-4, which contains a BamHI linker inserted into the Sst I site at position -22 in the yeast TOP) sequence (numbered from the first ATG of the coding sequence), was linearized with BamHI. The DNA was treated with BAL-31 nuclease (New England Biolabs), and the reaction was terminated at vhrious times by phenol extraction and ethanol precipitation. The DNA ends, which were filled in with the Klenow fragment of DNA polymerase I, were subsequently ligated together in the presence of an excess of phosphorylated Nco I linkers. These recircularized DNAs were transformed into E. coli strain MM294. Each mixture of ttansformants was grown in Luria broth plus ampicillin (or carbenicillin), and plasmid DNA was obtained by the NaOH/NaDodSO4 lysis procedure (24) . The rationale for this step was to increase the DNA concentrations for the subsequent low-efficiency transformations of strain AS17. The Nco I-Pvu I fragments of the MM294 "amplified" DNAs, containing the TOP) deletions, were gel purified in low-melting-temperature agarose and ligated with the gel-purified Pvu I-Nco I fragment of plasmid ptacl2B, thus placing the yeast topoisomerase I deletions downstream from the tac promoter. Following transformations of strain AS17 with these DNAs, ampicillin-resistant colonies were selected and assayed individually for the presence of yeast topoisomerase I antigenic determinants as described below. Total cellular proteins were resolved by NaDodSO4/polyacrylamide gel electrophoresis (25) , electroblotted onto nitrocellulose sheets, and immunostained using rabbit antibodies against yeast DNA topoisomerase I and horseradish peroxidase-based immunodetection reagents (Bio-Rad).
Topoisomerase I Activity Assays. Bacterial cell extracts for activity assays were prepared from 10 ml of overnight cultures as described (15, 26 Mg2+ in the assay mixture ensures that the DNA relaxation activity assayed is that of the yeast enzyme, since the divalent metal ion is required by all known E. coli DNA topoisomerases (1, 2). In both instances, the reaction was terminated by the addition of NaDodSO4 to 1% and heating at 60'C for 2 min. The extent of DNA relaxation was assayed by electrophoresis in a 0.7% agarose gel as described (29) . In Vivo Complementation. Complementation of the AS17 temperature-sensitive growth phenotype by plasmids expressing the yeast TOP) gene or its deletion mutations was determined by assaying cell viability at 30'C and 370C. AS17 transformants were grown in Luria broth containing ampicillin or carbenicillin. Serial dilutions of these cultures were plated and incubated at the permissive and nonpermissive temperatures, and the number of cells forming colonies were counted.
Rapid Lysis of Cells and the Isolation of Plasmids for Linking-Number Measurements. The NaOH/NaDodSO4 lysis procedure (24) was adapted for the rapid lysis of cells. Basically, 100 ml of cultures in 500-ml Erlenmeyer flasks on a gyratory shaker (New Brunswick) were rapidly lysed by pouring in an equal volume of a mixture containing 2-4% (wt/vol) NaDodSO4 and 0.2 M NaOH. Following neutralization and precipitation of the detergent with 75 ml of 5 M potassium acetate (pH 4.8), the supernatant was cleared by centrifugation at 5000 x g for 10 min and filtered through cheesecloth. The DNA was precipitated with 2 vol of ethanol and pelleted at 12,000 x g for 15 min. Plasmid DNA was subsequently purified by banding in CsCl/ethidium gradients (30) , at 150,000 x g; a broad layer below the nicked DNA band was collected to minimize the preferential loss of covalently closed topoisomers with linking numbers that differ significantly from the predominant topoisomers. After the removal of CsCl and ethidium, the linking number distributions of the DNA samples were analyzed by twodimensional gel electrophoresis as described (31) Yeast DNA Topoisomerase I Can Complement a Conditional-Lethal E. coli topA Mutation. E. coli strain AS17 topAampLL1(supDts) exhibits a conditionally lethal topA phenotype, resulting from the temperature-sensitive supression of a topA amber mutation.* As shown in Table 1 , increasing the incubation temperature from 30°C to 37°C decreases the viability of AS17 cells by >100-fold. This temperaturesensitive phenotype is rescued, however, by transforming the strain with ptacTOP1 or ptacTOPla, both of which express the entire coding sequence of yeast DNA topoisomerase I. Some of the ptacTOP1 derivatives with portions of the 5'-terminal coding sequences deleted can also complement the topA ts phenotype.
Results tabulated in Table 1 suggest that the genetic complementation of topA by TOPI requires the production of enzymatically active yeast DNA topoisomerase I. The frameshift mutant ptacTOPlA75fs, for example, is completely ineffective in rescuing the topA ts phenotype. All of the plasmids that can restore AS17 cell viability yield active yeast DNA topoisomerase I in extracts. However, the converse is not true: plasmids that express amino-terminal deletions of A rapid lysis procedure was used to minimize the possibility of altering the linking numbers of the plasmids during or after cell lysis. Fig. 2 shows the electrophoresis patterns of several samples in an agarose gel. The electrophoresis buffer contained an optimal concentration of chloroquine for the resolution of topoisomers of different linking numbers. Positively and negatively supercoiled topoisomers with linking differences of the same absolute values are often unresolved by one-dimensional agarose gel electrophoresis, which introduces some uncertainty into the interpretation of the results depicted in Fig. 2 . Two-dimensional agarose gel electrophoresis of the same samples, however, resolves all topoisomers (31, 32) . On the left of Fig. 3 , the arc of spots are topoisomers of ptacTOP1 purified from uninduced NK7048 topA' lacIql cells. The spot marked by an arrow is nicked ptacTOP1 DNA. The lower tip of the arc corresponds to topoisomers of the lowest linking numbers (i.e., the most negatively supercoiled). The linking numbers increase as the spots move up along the arc, and adjacent spots differ by one in their linking numbers (see refs. 1 and 31 for further interpretation of the two-dimensional patterns). Upon induction of TOP), the arc of spots extends toward higher linking numbers (in the center of Fig. 3 Fig. 3 ). The two-dimensional results shown in Fig. 3 confirm the interpretation of the one-dimensional results (Fig. 2) Inside E. coli, there might be subtle differences in the actions of the eukaryotic and prokaryotic enzymes. E. coli DNA topoisomerase I relaxes highly negatively supercoiled DNA very rapidly; it becomes less effective as the degree of negative supercoiling decreases (11) . Thus, the enzyme appears to be well-suited to keeping intracellular DNA moderately negatively supercoiled. In contrast, the rate of relaxation by the eukaryotic enzyme, which is independent of Although E. coli cannot tolerate a high degree of negative supercoiling resulting from inactivation of DNA topoisomerase I, it is unknown if there is a lower limit of supercoiling that is required for viability. The results depicted in Fig. 3 show that induction of the TOP] gene in cells harboring ptacTOP1 yields a broad topoisomer distribution with a range of =45 in linking number or -0.09 in specific-linking difference. Although topoisomers near the high linking-number end of the arc shown in the center of Fig. 3 are close to being completely relaxed, the presence of topoisomers with much lower linking numbers persists. We do not know if these plasmids come from a subpopulation, or if there is a dynamic equilibrium among the different topoisomers. These uncertainties make it difficult to interpret the physiological effects of very low degrees of supercoiling in bacteria and to extrapolate supercoiling studies done with plasmids to the chromosomal DNA (see the discussion in ref. 33 for the differences in supercoiling due to transcription of plasmids and chromosomal DNA loops).
We found that -130 amino acids or 18% of the total can be deleted from the amino terminus of yeast DNA topoisomerase I without inactivating in vitro activity of the enzyme. This accounts, at least in part, for earlier preparation procedures yielding a 60-kDa eukaryotic DNA topoisomerase I (reviewed in refs. 1 and 2). Some of the amino-terminal deletions are active in vitro but inactive inside E. coli; it should be of interest to test if the same is true in yeast and if the portions deleted affect the functions of the enzyme.
Finally, we note that a number of antibiotics and antitumor drugs have been found to act by blocking the DNA resealing step in the topoisomerase-catalyzed DNA-strand breakage and rejoining (reviewed in ref. 4) . Whereas most of the known drugs act on the type II topoisomerases, the drug camptothecin acts on eukaryotic DNA topoisomerase I (34) . The present work establishes that yeast DNA topoisomerase I, and presumably the same enzyme from other eukaryotes including humans, can be expressed in a catalytically active form inside E. coli. Such a system may be useful in the screening of drugs acting on eukaryotic DNA topoisomerase I.
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